US Patent 12076411 Anti-HER2 antibody-maytansine conjugates and methods of use thereof
Patent 12076411 was granted and assigned to Redwood Bioscience on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+32 properties)
Article (+210 characters)
US Patent 12076411 Anti-HER2 antibody-maytansine conjugates and methods of use thereof
Article
Patent abstract
The present disclosure provides anti-HER2 antibody-maytansine conjugate structures. The disclosure also encompasses methods of production of such conjugates, as well as methods of using the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Aaron Edward Albers0
Albert W. Garofalo0
David Rabuka0
Gregory W. deHart0
Jesse M. McFarland0
Penelope M. Drake0
Robyn M. Barfield0
Romas Alvydas Kudirka0
Date of Patent
September 3, 2024
0Patent Application Number
173830760
Date Filed
July 22, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12076411 Anti-HER2 antibody-maytansine conjugates and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.